ACTRN12614001243606
Recruiting
Phase 3
Comparison between the synergistic use of oral contraceptives and fluoxetine vs fluoxetine alone in the management of premenstrual syndrome
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Cairo university
- Enrollment
- 210
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 20\-40 years
- •Premenstrual syndrome
- •Nulligravida
Exclusion Criteria
- •Hypertension
- •Liver disease
- •History of DVT
- •Allergy to fluoxetine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Comparison of the effect of COCs and vitamin D-COCs on ovulatory dysfunction Bleeding in reproductive age womeOvulatory dysfunction bleeding.Other specified abnormal uterine and vaginal bleedingN93.8IRCT20110606006709N22Tabriz University of Medical Sciences60
Not yet recruiting
Phase 4
Comparative study on the impact of combined oral contraceptive pills and Progestrogen only pills on the prevalence of bacterial vaginosis using Nugent score : a randomized-controlled trialTo study prevalence of bacterial vaginosisTCTR20190313002Faculty of Medicine Siriraj Hospital, Mahidol University200
Completed
Not Applicable
sage of two different mouth cleaning aids in blind children of residential schools.CTRI/2018/05/014171Vajrala Deepika90
Not yet recruiting
Phase 2
To study the efficacy of administration of metformin into thyroid nodules and compare it with oral metformin in patients with benign goiter and normal thyroid functioHealth Condition 1: E049- Nontoxic goiter, unspecifiedCTRI/2019/07/020053IPGMER
Active, not recruiting
Phase 1
Study to compare the effectiveness of drinking water or receiving endovenous hydration to prevent complications in the kidney in patients with renal insufficiency grade III underwent performing computed tomography (CT)Patients with renal failure undergoing a computed tomography scan with contrastMedDRA version: 19.0Level: PTClassification code 10038435Term: Renal failureSystem Organ Class: 10038359 - Renal and urinary disordersTherapeutic area: Not possible to specifyEUCTR2016-002032-33-ESFundacio Privada Clinic per a la Recerca Biomedica